Palatin Technologies
PTN
#10224
Rank
โ‚ฌ23.29 M
Marketcap
13,09ย โ‚ฌ
Share price
5.76%
Change (1 day)
16,239.85%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚ฌ4.7 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ8.84 Million. In 2024 the company made an earning of -โ‚ฌ23.14 Million, an increase over its 2023 earnings that were of -โ‚ฌ27.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ4.7 Million-79.73%
2024 -โ‚ฌ23.14 Million-16.9%
2023 -โ‚ฌ27.85 Million5.99%
2022 -โ‚ฌ26.28 Million-13.7%
2021 -โ‚ฌ30.45 Million33.25%
2020 -โ‚ฌ22.85 Million-172.11%
2019 โ‚ฌ31.68 M2352.33%
2018 โ‚ฌ1.29 M-94.13%
2017 โ‚ฌ22.01 M-154.92%
2016 -โ‚ฌ40.09 Million3.67%
2015 -โ‚ฌ38.67 Million878%
2014 -โ‚ฌ3.96 Million-72.64%
2013 -โ‚ฌ14.45 Million-33.11%
2012 -โ‚ฌ21.61 Million77.71%
2011 -โ‚ฌ12.16 Million
2003 -โ‚ฌ20.59 Million29.93%
2002 -โ‚ฌ15.85 Million36.18%
2001 -โ‚ฌ11.64 Million
1999 -โ‚ฌ9.66 Million6.04%
1998 -โ‚ฌ9.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.31 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.59 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.68 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ10.32 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.14 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ82.28 M-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.33 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ49.78 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA